Nobel Prize Honors Pioneering Immune System Research
The Nobel Prize in Physiology or Medicine was awarded for transformative findings that illuminate how the immune system attacks harmful pathogens while sparing the body's own cells.
A trio of renowned scientists—Japan's Shimon Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this honor.
Their work identified specialized "sentinels" within the defense system that eliminate rogue immune cells that could harming the organism.
The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.
These laureates will divide a monetary award worth 11 million Swedish kronor.
Crucial Discoveries
"The work has been decisive for comprehending how the body's defenses operates and the reason we don't all develop serious autoimmune diseases," stated the chair of the award panel.
This trio's studies address a fundamental mystery: How does the defense system protect us from numerous infections while keeping our healthy cells intact?
The immune system employs immune cells that search for indicators of disease, including viruses and germs it has never encountered.
These defenders utilize sensors—called recognition units—that are produced randomly in a vast number of variations.
That gives the defense network the ability to combat a wide array of invaders, but the unpredictability of the process inevitably produces white blood cells that can target the host.
Security Guards of the Immune System
Researchers previously knew that some of these problematic white blood cells were destroyed in the immune organ—the site where immune cells develop.
The latest award honors the identification of T-reg cells—known as the body's "security guards"—which travel through the system to disarm other defenders that attack the body's own tissues.
It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.
The prize committee stated, "The discoveries have laid the foundation for a new field of research and accelerated the creation of new treatments, for instance for cancer and autoimmune diseases."
Regarding malignancies, regulatory T-cells prevent the system from attacking the growth, so studies are focused on lowering their quantity.
In self-attack disorders, trials are exploring increasing regulatory T-cells so the body is no longer under attack. A similar approach could also be effective in minimizing the risks of transplanted organ rejection.
Pioneering Studies
Prof Shimon Sakaguchi, of Osaka University, performed experiments on rodents that had their thymus extracted, causing autoimmune disease.
He showed that injecting immune cells from healthy animals could prevent the illness—implying there was a system for blocking immune cells from harming the body.
Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an genetic immune disorder in rodents and humans that resulted in the discovery of a gene critical for the way T-regs function.
"Their groundbreaking research has revealed how the immune system is controlled by regulatory T cells, stopping it from mistakenly attacking the healthy cells," said a leading physiology specialist.
"The work is a striking illustration of how basic physiological research can have far-reaching implications for public health."